Total raised
—
Last: Pre-Seed 2023-12
Stage
Pre-Seed
Founded
2015
Headcount
6
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
NanoCell is dedicated to advancing womens reproductive health through biopharmaceutical technologies. The companys proprietary intrauterine treatment significantly improves embryo implantation, thereby increasing the chances of conception. NanoCell is developing a method, kit, and composition for increasing the implantation rate of embryos in both humans and livestock using enzymatically remodeled extra-cellular matrix (ECM) to improve the efficiency of embryo implantation.
Funding history · 1 round · — total
2023-12
Pre-Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is NanoCell's primary focus?
- NanoCell is dedicated to advancing women's reproductive health through biopharmaceutical technologies, specifically developing an intrauterine treatment to improve embryo implantation rates.
- When was NanoCell founded?
- NanoCell was founded in January 2015.
- What is the current operational status of NanoCell?
- NanoCell is currently inactive, having ceased to operate in August 2024.
- Where is NanoCell headquartered?
- NanoCell is headquartered in Rehovot, Israel.
- Who is a key founder of NanoCell?
- Prof. Irit Sagi is a founder of NanoCell.
- What was NanoCell's last known funding round?
- NanoCell's last known funding round was a Pre-Seed round in December 2023, with Arieli Group as a lead investor.
- What technology is NanoCell developing for embryo implantation?
- NanoCell is developing a method, kit, and composition that uses enzymatically remodeled extra-cellular matrix (ECM) to improve the efficiency of embryo implantation in both humans and livestock.
- What is NanoCell's employee count?
- NanoCell had 6 employees.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesImplantsComposites
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomenAgriculture & FoodLivestock
Business model
B2B
Highlights
1 Patents
Tags
femtechcomposite-materialswomen-healthmedical-devicesfertilitywomenpregnancymedical-technologiesbiopharmaceuticallivestock